Companies › Eli Lilly › Diluted shares
Eli Lilly weighted average diluted shares outstanding, 2008–2025
Eli Lilly reported weighted average diluted shares outstanding of 899.3 million shares for the fiscal year ended Dec. 31, 2025, down 0.5% from 904.1 million shares the year before, according to its Form 10-K.
Fiscal years labeled by the year in which they ended. Bars drawn from the table below.
Eli Lilly weighted average diluted shares outstanding by fiscal year
| Fiscal year ended | Diluted shares | Change | Filing |
|---|---|---|---|
| Dec. 31, 2025 | 899.3M shares | −0.5% | 10-K (2026) ↗ |
| Dec. 31, 2024 | 904.1M shares | +0.1% | 10-K (2026) ↗ |
| Dec. 31, 2023 | 903.3M shares | −0.1% | 10-K (2026) ↗ |
| Dec. 31, 2022 | 904.6M shares | −0.8% | 10-K (2025) ↗ |
| Dec. 31, 2021 | 911.7M shares | −0.1% | 10-K (2024) ↗ |
| Dec. 31, 2020 | 912.5M shares | −2.5% | 10-K (2023) ↗ |
| Dec. 31, 2019 | 935.7M shares | −9.5% | 10-K (2022) ↗ |
| Dec. 31, 2018 | 1.03B shares | −1.7% | 10-K (2021) ↗ |
| Dec. 31, 2017 | 1.05B shares | −0.9% | 10-K (2020) ↗ |
| Dec. 31, 2016 | 1.06B shares | −0.4% | 10-K (2019) ↗ |
| Dec. 31, 2015 | 1.07B shares | −0.8% | 10-K (2018) ↗ |
| Dec. 31, 2014 | 1.07B shares | −1.0% | 10-K (2017) ↗ |
| Dec. 31, 2013 | 1.08B shares | −2.9% | 10-K (2016) ↗ |
| Dec. 31, 2012 | 1.12B shares | +0.3% | 10-K (2015) ↗ |
| Dec. 31, 2011 | 1.11B shares | +0.7% | 10-K (2014) ↗ |
| Dec. 31, 2010 | 1.11B shares | +0.7% | 10-K (2012) ↗ |
| Dec. 31, 2009 | 1.10B shares | +0.4% | 10-K (2012) ↗ |
| Dec. 31, 2008 | 1.09B shares | — | 10-K (2011) ↗ |
Other Eli Lilly financials
RevenueNet incomeDiluted EPSR&D expenseOperating cash flowDividends per shareTotal assetsCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub
FAQ
Q What was Eli Lilly's weighted average diluted shares outstanding in its latest fiscal year?
A Eli Lilly reported weighted average diluted shares outstanding of 899.3 million shares for the fiscal year ended Dec. 31, 2025, down 0.5% from 904.1 million shares the year before, according to its Form 10-K.
Q What is Eli Lilly's highest annual weighted average diluted shares outstanding on record here?
A 1.12 billion shares, in the fiscal year ended Dec. 31, 2012, among the fiscal years 2008–2025 reported in its 10-K XBRL data.
Q Where does this weighted average diluted shares outstanding data come from?
A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Weighted average diluted shares outstanding for the year, as reported. Years before the latest stock split are left out rather than adjusted.
Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Weighted average diluted shares outstanding for the year, as reported. Years before the latest stock split are left out rather than adjusted. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.